On November 21, 2019, Kagocel was recognized as the best imported antiviral drug for the treatment of influenza and ARVI at the international contest Choice of the Year 2019 in Belarus.
«For the second year in a row, Kagocel wins in the category „Antiviral drug for the treatment of influenza and ARVI (from the interferon group) of imported production“ at a contest in the Republic of Belarus. Of course, this is good news for our company, proving that the drug enjoys well-deserved popularity not only in Russia, but also abroad,» said Yuri Sidnev, head of the Medicine Promotion and Sales Department at the Nearmedic group.
The contest is aimed at improving the quality and competitiveness of goods and services sold on the territory of the Republic of Belarus in the interests of customers. The Choice of the Year gold medal is awarded based on professional marketing research of preferences in different consumer groups. The methodology for determining the winners of the Choice of the Year project is comprehensive, it is the same in all countries of the project and allows one to evaluate the product or service from different angles, thus bringing the results as close as possible to objectivity.